Correlation Between ENDRA Life and Vyne Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ENDRA Life and Vyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ENDRA Life and Vyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ENDRA Life Sciences and Vyne Therapeutics, you can compare the effects of market volatilities on ENDRA Life and Vyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ENDRA Life with a short position of Vyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ENDRA Life and Vyne Therapeutics.

Diversification Opportunities for ENDRA Life and Vyne Therapeutics

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between ENDRA and Vyne is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding ENDRA Life Sciences and Vyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vyne Therapeutics and ENDRA Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ENDRA Life Sciences are associated (or correlated) with Vyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vyne Therapeutics has no effect on the direction of ENDRA Life i.e., ENDRA Life and Vyne Therapeutics go up and down completely randomly.

Pair Corralation between ENDRA Life and Vyne Therapeutics

Given the investment horizon of 90 days ENDRA Life Sciences is expected to under-perform the Vyne Therapeutics. In addition to that, ENDRA Life is 1.39 times more volatile than Vyne Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. Vyne Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest  374.00  in Vyne Therapeutics on August 30, 2024 and sell it today you would lose (79.00) from holding Vyne Therapeutics or give up 21.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ENDRA Life Sciences  vs.  Vyne Therapeutics

 Performance 
       Timeline  
ENDRA Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ENDRA Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Vyne Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vyne Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Vyne Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

ENDRA Life and Vyne Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ENDRA Life and Vyne Therapeutics

The main advantage of trading using opposite ENDRA Life and Vyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ENDRA Life position performs unexpectedly, Vyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vyne Therapeutics will offset losses from the drop in Vyne Therapeutics' long position.
The idea behind ENDRA Life Sciences and Vyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.